BPG is committed to discovery and dissemination of knowledge
Original Article
©2011 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastrointest Surg. Aug 27, 2011; 3(8): 113-118
Published online Aug 27, 2011. doi: 10.4240/wjgs.v3.i8.113
Proximal and distal rectal cancers differ in curative resectability and local recurrence
Sumudu K Kumarage, Kemal I Deen, S Ruwan Wijesuriya, Raeed Deen, Jayantha Balawardena, Mahendra Perera, Wasantha Wijenayake
Wasantha Wijenayake, Department of Surgery, National Hospital, Colombo, Sri Lanka
Mahendra Perera, Jayantha Balawardena, Department of Oncology, National Cancer Institute, Maharagama, Sri Lanka
Raeed Deen, S Ruwan Wijesuriya, Sumudu K Kumarage, Kemal I Deen, Department of Surgery, University of Kelaniya Medical School, Ragama, Sri Lanka
Author contributions: Wijenayake W was responsible for the concept and design, data acquisition, data analysis of this paper, and wrote, approved the final version of the manuscript; Perera M, Balawardena J and Wijesuriya SR were responsible for the concept, revised draft and approved the final version of the paper; Deen R was responsible for the concept, data entry, data acquisition and analysis of this paper and approved the final version of the manuscript; Kumarage SK was responsible for the revised draft, approved final version of this manuscript; Deen KI was responsible for the concept and design, data analysis and interpretation of this paper, and revised several drafts, approved final version of the manuscript.
Correspondence to: Kemal I Deen, MS, MD, FRCS, Professor, Department of Surgery, University of Kelaniya Medical School, PO Box 6, Talagolla Road, Ragama, Sri Lanka. radihan@mail.ewisl.net
Telephone: +94-1-2737702 Fax: +94-1-2737702
Received: March 5, 2011
Revised: August 10, 2011
Accepted: August 16, 2011
Published online: August 27, 2011
Abstract

AIM: To evaluate patients with proximal rectal cancer (PRC) (> 6 cm up to 12 cm) and distal rectal cancer (DRC) (0 to 6 cm from the anal verge).

METHODS: Two hundred and eighteen patients (120 male, 98 female, median age 58 years, range 19-88 years) comprised 100 with PRC and 118 with DRC. The proportion of T1, T2 vs T3, T4 stage cancers was similar in both groups (PRC: T1+T2 = 29%; T3+T4 = 71% and DRC: T1+T2 = -31%; T3+T4 = 69%). All patients had cancer confined to the rectum - those with synchronous distant metastasis were excluded. Surgical resection was with curative intent with or without pre-operative chemoradiation (c-RT). Follow-up was for a median of 35 mo (range: 12 to 126 mo). End points were: 30 d mortality, complications of operation, microscopic tumour- free margins, resection with a tumour-free circumferential margin (CRM) of 1 to 2 mm and > 2 mm, local recurrence, survival and the permanent stoma rate.

RESULTS: Overall 30-d mortality was 6% (12): PRC 7 % and DRC 4%. Postoperative complications occurred in 14% with PRC compared with 21.5% with DRC, urinary retention was the complication most frequently reported (PRC 2% vs DRC 9%, P = 0.04). Twelve percent with PRC compared with 37% with DRC were subjected to preoperative c-RT (P = 0.03). A tumour-free CRM of 1 to 2 mm and > 2 mm was reported in 93% and 82% with PRC and 88% and 75% with DRC respectively (PRC vs DRC, P > 0.05). However, local recurrence was 5% for PRC vs 11% for DRC (P < 0.001). Three and five years survival was 65.6% and 60.2% for PRC vs 67% and 64.3% for DRC respectively. No patient with PRC and 23 (20%) with DRC received an abdomino-perineal resection.

CONCLUSION: PRC and DRC differ in the rate of abdomino-perineal resection, post-operative urinary retention and local recurrence. Survival in both groups was similar.

Keywords: Rectal cancer; Pre-operative chemoradiation; Inter-sphincteric resection; Local recurrence; Survival
Write to the Help Desk